Amid Attacks On PBMs, Hatch-Walden Letter To OMB A Good Turn For The Middlemen

By John Wilkerson / August 10, 2018 at 5:42 PM
The chairs of the Senate Finance and House Energy & Commerce committees on Thursday (Aug. 9) asked the White House budget chief to carefully calculate the economic impact of changes HHS is considering to the anti-kickback law’s treatment of drug rebates. The letter is considered beneficial to pharmacy benefit managers that have the most to lose from changes to anti-kickback law’s safe harbors. The letter is an example of the policy judo over drug prices as pharmacy benefit managers get...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.